Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021



Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

Industry Veteran Matthew Cranfill, RN, BSN, WOCN, Will Lead the Company's NPWT Clinical Support & Education.

Matthew Cranfill, RN, BSN, WOCN, has been named as Director of Clinical Services reports ExtriCare USA today.

Matthew Cranfill will oversee ExtriCARE USA’s clinical services, focusing on product development and wound care education. With over 23 years of clinical experience and a distinguished track record in wound healing, Cranfill will take ExtriCARE USA’s clinical program to the next level.

“Matt’s impressive experience and skillset easily made him our top pick,” said Peter Mason, President of ExtriCARE USA. “His eagerness to innovate and hands-on approach deeply aligns with our company vision. Matt brings tremendous value to our expanding team, and I’m excited about the impact he will have on our future growth.”

Combining his extensive background and passion for wound healing, Cranfill brings the dedication and leadership necessary to drive ExtriCARE USA’s clinical services. He has a keen eye for figuring out how to improve patient outcomes and clinician satisfaction.

“I’m thrilled to be joining ExtriCARE USA’s forward-thinking team at such a pivotal time in wound care,” said Cranfill. “There’s a lot of potential for growth and innovation in the NPWT market, and I look forward to applying my clinical perspective to enhance the outcomes for the clients, clinicians and patients who use our products.”

ExtriCARE USA firmly believes in NPWT’s potential and is proactively investing in its future. The company is cultivating a strong network of dealers who will have direct clinical support and educational resources. ExtriCARE USA’s goal is to boost the growth and success of NPWT, optimizing clinician satisfaction and the patient healing experience.

Looking ahead, ExtriCARE USA will be launching new portable, powerful and adaptive NPWT solutions to the market.


Other Articles

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Eliaz Therapeutics is Raising Capital

The XGAL3® therapeutic apheresis device is the early-mover for the treatment of AKI. ETI has demonstrated significant survival benefits in preclinical models and their prototype device has successfully removed GAL-3 from human blood plasma.

Veranex Announces Acquisition of IMMR

IMMR, a leading preclinical science organization that provides preclinical research, pathology evaluation and surgical training services to medical technology innovators.

By using this website you agree to accept Medical Device News Magazine Privacy Policy